As previously announced, the UK government has enacted legislation to continue the recognition of the CE marking indefinitely for a range of products falling within the scope of 21 regulations, including toys, radio...more
Nowadays, artificial intelligence (“AI”) is all around us. Previously, we took a look at the approaches being proposed to regulate AI at a pan-EU level and in the UK.
In this part 2 article, we take a look at what...more
The role that artificial intelligence (“AI”) plays in our everyday lives continues to grow. As a result, so do the proposals surrounding how to regulate AI as well as its relationship with products and end users....more
With the aim of showcasing the successes of Safety Gate in ensuring product safety across the Single Market, the European Commission published the results of its 2022 Report, outlining how technology, the sharing of...more
New Sustainable Batteries Regulation: Reflections from our Global Products Law team
Following the closure of the European Commission’s recent consultation period, the European Parliament and Council are set to consider a...more
With the EU Chemical Agency's recent announcement that four new substances will be added to the Candidate List1, you might be thinking: what's next for the UK and its chemicals legislation?...more
2/6/2020
/ Chemicals ,
Covered Products ,
ECHA ,
Environmental Policies ,
EU ,
Foreign-Made Goods ,
Goods or Services ,
Manufacturers ,
Public Health ,
REACH ,
UK ,
UK Brexit ,
Withdrawal Agreement
We are excited to bring you issue 76 of our International Products Law Review with insights and updates on all aspects of products law. In this issue, we explore what businesses need to consider when making climate-related...more
1/13/2020
/ Appeals ,
Business Litigation ,
Carbon Emissions ,
Causation ,
Class Action ,
Climate Change ,
Consent ,
Consumer Protection Laws ,
Cookies ,
Court of Justice of the European Union (CJEU) ,
Cybersecurity ,
Disclosure ,
Energy Efficiency ,
EU ,
European Court of Justice (ECJ) ,
Evidence ,
Germany ,
GlaxoSmithKline ,
Legislative Agendas ,
Litigation Funding ,
Litigation Strategies ,
Multidistrict Litigation ,
Opioid ,
Opt-In ,
Pharmaceutical Industry ,
Prescription Drugs ,
Project Management ,
Regulatory Agenda ,
Vaccinations